4 Lessons From FTC's Successful Bid To Block Edwards Deal

By Eric Hochstadt, Craig Falls and Tony Chan ( February 3, 2026, 5:27 PM EST) -- The Federal Trade Commission's recent victory blocking Edwards Lifesciences Corp.'s proposed acquisition of JenaValve Technology Inc. offers lessons for parties advancing future transactions for innovators of medical devices, in the life sciences and any industry heavy in research and development, while also highlighting risks for parties negotiating mergers and acquisitions....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login